T1	Participants 159 177	bipolar 1 disorder
T2	Participants 210 253	patients with manic and mixed mood episodes
T3	Participants 486 532	patients presenting with a mixed index episode
T4	Participants 603 725	Patients who met remission criteria at 2 consecutive weekly visits during 6 to 12 weeks of open-label olanzapine treatment
T5	Participants 968 1068	121 of 304 patients (39.8%) met criteria for symptomatic remission in the open-label treatment phase
T6	Participants 1677 1745	patients presenting with a mixed index episode of bipolar I disorder
